Ignite Creation Date:
2024-05-05 @ 5:12 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00409084
Status:
TERMINATED
Last Update Posted:
2010-07-05
First Post:
2006-12-06
Brief Title:
Beta Blockers Versus Variceal Band Ligation and Beta Blockers for Primary Prophylaxis of Variceal Bleeding
Sponsor:
Virginia Commonwealth University
Organization:
Virginia Commonwealth University
Study Overview
Official Title:
Beta Blockers Versus Variceal Band Ligation and Beta Blockers for Primary Prophylaxis of Variceal Bleeding
Status:
TERMINATED
Status Verified Date:
2010-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Lack of enrollment
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Patients with scarring of the liver cirrhosis and portal hypertension elevated blood pressure in the liver vasculature can develop esophageal varices dilated veins These have an increased risk of bleeding each year Current recommendations are to prevent bleeding of medium or large varices when there is no history of bleeding by starting a blood pressure lowering agent known as a non-selective beta-blocker Alternatively rubber bands can be placed on medium to large varices to prevent bleeding endoscopic variceal band ligation Using both therapies at the same time has not been studied In this study we hope to determine if the use of combination therapy with endoscopic variceal band ligation and beta blockers is more effective than using beta blockers alone to prevent the first bleeding episode from the varices dilated veins The efficacy ability to tolerate and cost-effectiveness of these two treatment strategies will be compared
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None